Amgen nelle notizie
Sviluppo di terapie umane innovative
Tamtam ha trovato 20 articoli recenti su Amgen.
- How Investors Are Reacting To Amgen (AMGN) Earnings Beat
- Amgen Inc. stock outperforms competitors on strong trading day
- Amgen announces Sjogren's trial results: Amgen stock gains 1.59 percent
- Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis
- Truist raises Amgen stock price target to $380 on pipeline growth
- Amgen (NASDAQ:AMGN) Stock Price Expected to Rise, Truist Financial Analyst Says
- Amgen (AMGN) Advances While Market Declines: Some Information for Investors
- Ada Visa Joins Amgen as Global Development Scientist Director
- Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
- 3,524 Amgen Inc. $AMGN Shares Sold by Colton Groome Financial Advisors LLC
- Amgen stock faces a USD 400 Cantor Fitzgerald target
- 2,546 Amgen Inc. $AMGN Shares Sold by Argent Capital Management LLC
- Why is Amgen (NASDAQ:AMGN) stock in focus as its obesity pipeline advances?
- Cantor Fitzgerald reiterates Amgen stock Neutral rating at $400 By Investing.com
- David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon Petroleum
- Amgen (NASDAQ:AMGN) Stock Purchase Disclosed by Rep. David Taylor
- Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock
- The biotech process development associate in Amgen’s grad programme
- Amgen (NASDAQ:AMGN) Scores Late-Stage Immunology Win
- More Than Skin Deep: Understanding Discoid Lupus Erythematosus
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Amgen?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili